NCT03129880

Brief Summary

The purpose of this study is to determine if there are differences in treatment outcomes between traditional voice therapy, performed weekly for a maximum of 6 weeks versus intensive voice therapy, consisting of 4-6 therapy sessions performed within one day.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 13, 2016

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 18, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 26, 2017

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 12, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2024

Completed
Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

8 years

First QC Date

April 18, 2017

Last Update Submit

May 15, 2024

Conditions

Keywords

Voice disorderHoarsenessPhonation DisordersSpeech Disorders

Outcome Measures

Primary Outcomes (2)

  • Self-efficacy and readiness scale Changes

    Pre to Post difference in participant's self-efficacy for voice practice and healthy voice technique between therapy groups and within subsets of subjects - readiness ruler of 0 (not at all) to 10 (extremely)

    Baseline compared to Immediately post voice therapy

  • Self-efficacy and readiness scale Change

    Pre to Post difference in participant's self-efficacy for voice practice and healthy voice technique between therapy groups and within subsets of subjects - readiness ruler of 0 (not at all) to 10 (extremely)

    Baseline compared to 12 weeks post voice therapy

Study Arms (2)

Weekly Voice Therapy

PLACEBO COMPARATOR

Participants are randomized to receiving weekly voice therapy sessions

Behavioral: Weekly Voice Therapy

Intensive Voice Therapy

ACTIVE COMPARATOR

Participants are randomized to receiving multiple sessions of voice therapy in one day

Behavioral: Intensive Voice Therapy

Interventions

Participants will be randomized to receive weekly voice therapy

Weekly Voice Therapy

Participants will be randomized to receive multiple sessions of voice therapy in one day.

Intensive Voice Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with a Voice disorder
  • Diagnosed with benign vocal fold lesions and/or hyper-function
  • First/primary propose treatment modality is voice therapy
  • Patients who are appropriate for either standard of care treatment modality (traditional or intensive voice therapy)
  • Willingness to participate in either standard of care treatment modality
  • All races
  • Males and females
  • English speaking

You may not qualify if:

  • Younger than 18
  • Inability or unwillingness to participate in one of the standard of care treatment modalities
  • Laryngeal Surgery or procedures during course of study
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin-Madison Voice and Swallow Clinic

Madison, Wisconsin, 53792, United States

Location

MeSH Terms

Conditions

DysphoniaVoice DisordersHoarsenessSpeech Disorders

Condition Hierarchy (Ancestors)

Laryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsRespiration DisordersSigns and Symptoms, RespiratoryLanguage DisordersCommunication DisordersNeurobehavioral Manifestations

Study Officials

  • Emerald J Doll, MS, CCC-SLP

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: For purposes of this study participants will be randomized into one of the following two groups: 4-6 weekly standard of care therapy sessions, once a week, for a maximum of six weeks 4-6 standard of care therapy sessions in one day Standard of care treatment may continue past patient enrollment in this study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 18, 2017

First Posted

April 26, 2017

Study Start

March 13, 2016

Primary Completion

March 12, 2024

Study Completion

March 12, 2024

Last Updated

May 16, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations